Depot medroxyprogesterone injectable contraception at the University of Uyo Teaching Hospital, Uyo

Background: Depot medroxyprogesterone acetate is the most studied injectable contraceptive and also one of the most effective methods of contraception currently available. It is reversible, its use is independent of intercourse, and can be provided by trained non-medical staff making it particularly suitable for use in developing countries. The aim of this study is to determine the socio-demographic characteristics of its acceptors, the timing of use and complications at the University of Uyo Teaching Hospital, Uyo. Materials and Methods: The record cards of all clients who accepted medroxyprogesterone acetate injectable contraception over a nine-year period were studied. Results: There were 1065 new contraceptive acceptors out of which 166 (15.1%) accepted depot medroxyprogesterone acetate. The modal age group of the clients was 30-34 years (35.0%). Majority of clients were grandmultiparous (63.9%), married (82.0%), and 50.6% had primary level education. Majority of the clients (84.2%) derived their sources of information on contraception from clinic personnel and friends/relatives. All the clients received their injections within seven days of menstruation. The most common side effects were amenorrhea (12.0%) and spotting of blood per vaginam (10.8%). Conclusion: Depot medroxyprogesterone acetate is a safe form of contraception, which was mostly accepted by grandmultiparous women and those in their thirties. The involvement of the print and electronic media in the propagation of accurate information about depot medroxprogesterone acetate to members of the community and the introduction of post-abortal and puerperal administrations of depot medroxyprogesterone acetate and its new formulation; depo sub-Q provera in all our hospitals are advocated.Arri\ue8re-plan: SAV ac\ue9tate de m\ue9droxyprogest\ue9rone est le plus \ue9tudi\ue9 injectable contraceptive et aussi l\u2019une des m\ue9thodes plus efficaces de la contraception actuellement disponible. Il est r\ue9versible, son utilisation est ind\ue9pendante des rapports sexuels et peut \ueatre assur\ue9e par personnel non m\ue9dical qualifi\ue9 rend particuli\ue8rement adapt\ue9 \ue0 une utilisation dans les pays en d\ue9veloppement. L\u2019objectif de cette \ue9tude est de d\ue9terminer les caract\ue9ristiques sociod\ue9mographiques des ses acceptors, la dur\ue9e d\u2019utilisation et des complications \ue0 l\u2019h\uf4pital d\u2019enseignement Universit\ue9 de Uyo, Uyo. Patients and Methods: Les cartes d\u2019enregistrements de tous les clients qui ont accept\ue9 de contraception injectable d\u2019ac\ue9tate de m\ue9droxyprogest\ue9rone sur une p\ue9riode de neuf ans ont \ue9t\ue9 \ue9tudi\ue9s. R\ue9sultats: Il y a eu 1065 nouvelle contraception acceptors de laquelle ac\ue9tate de m\ue9droxyprogest\ue9rone d\ue9p\uf4t accept\ue9 de 166 (15,1%). Le groupe d\u2019\ue2ge modal des clients a \ue9t\ue9 30\u201334 ans (35,0%). La majorit\ue9 des clients ont \ue9t\ue9 grandmultiparous (63.9%), mari\ue9 (82.0%) et 50.6% avait niveau primaire. La majorit\ue9 des clients (84,2%) d\ue9riv\ue9 leurs sources d\u2019information sur la contraception personnel clinique et amis/famille. Tous les clients re\ue7us leurs injections dans les sept jours de menstruation. Les effets secondaires plus courantes \ue9taient am\ue9norrh\ue9e (12,0%) et spotting de sang par vaginam (10,8%). Conclusion: Ac\ue9tate de m\ue9droxyprogest\ue9rone SAV est une forme s\ue9curitaire de contraception, qui a \ue9t\ue9 accept\ue9e principalement par les femmes grandmultiparous et ceux dans les ann\ue9es trente. La participation des m\ue9dia imprim\ue9s et \ue9lectroniques dans la propagation des informations pr\ue9cises sur ac\ue9tate de m\ue9droxyprogest\ue9rone de d\ue9p\uf4t pour les membres de la Communaut\ue9 et l\u2019introduction des administrations post-abortal et puerp\ue9rale d\u2019ac\ue9tate de m\ue9droxyprogest\ue9rone de d\ue9p\uf4t et de sa nouvelle formulation ; subQ depo provera sont pr\ue9conis\ue9es